Autoimmune or infectious diseases often instigate the undesirable damages to tissues or
organs to trigger immune-related diseases, which involve plenty of immune cells, pathogens …

Vaccination using nanocarrier-based delivery systems has recently emerged as a promising
approach for meeting the continued challenge posed by infectious diseases and cancer. A …

Continued development of multivalent nanomaterials has provided opportunities for the
advancement of antigen-specific immunotherapies. New insights emerge when considering …

Rheumatoid arthritis (RA) is a joint-related autoimmune disease that is difficult to cure. Most
therapeutics act to alleviate the symptoms but not correct the causes of RA. Novel strategies …

Immunotherapy shows a lot of promise for addressing the problems with traditional cancer
treatments. Researchers and clinicians are working to create innovative immunological …

In spite of the progress of conventional vaccines, improvements are required due to
concerns about the low immunogenicity of the toxicity, instability, and the need for multiple …

Autoimmune diseases are chronic, destructive diseases that can cause functional disability
and multiple organ failure. Despite significant advances in the range of therapeutic agents …

Over the last two decades, the nanomedicine field has witnessed an explosive growth of
research on the development of nanoparticle/microparticle (NP/MP)-based compounds for …

The development of nanoparticles (NPs) with potential therapeutic uses represents an area
of vast interest in the scientific community during the last years. Recently, the pandemic …

Nanoparticles (NPs) have promising applications in medicine. Immune system is an
important protective system to defend organisms from non‐self matters. NPs interact with the …